Skip to main content

Advertisement

SpringerLink
Log in

Tuberculosis and HIV infection: A review

  • Review
  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Centers for Disease Control: 1993 Revised classification-system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41 (1992) No. RR-17.

  2. Raviglione, M. C., Snider, D., Kochi, A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 273 (1995) 220–226.

    Google Scholar 

  3. Shafer, R. W., Edlin, B. R. Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clin. Infect. Dis. 22 (1996) 683–704.

    Google Scholar 

  4. Barnes, P. F., Bloch, A. B., Davidson, P. T., Snider, D. E. Tuberculosis in patients with human immunodeficiency virus infection. N. Engl. J. Med. 324 (1991) 1644–1650.

    Google Scholar 

  5. Hopewell, P. C. Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin. Infect. Dis. 15 (1992) 540–547.

    Google Scholar 

  6. Pape, J. W., Jean, S. S., Ho, J. L., Hafner, A., Johnson, W. D. Effect of isoniazid prophylaxis on the incidence of active tuberculosis and progression of HIV infection. Lancet 342 (1993) 268–272.

    Google Scholar 

  7. Whalen, C., Horsburgh, C. R., Hom, D., Lahart, C., Simberkoff, M., Ellner, J. Accelerated course of human immunodeficiency virus infection after tuberculosis. J. Respir. Crit. Care Med. 151 (1995) 129–135.

    Google Scholar 

  8. Orme, I. M., Miller, E. S., Roberts, A. D., Furney, S. K., Griffin, J. P., Dobos, K. M., Chi, D., Rivoire, B., Brennan, P. J. T lymphocytes mediating protection and cellular cytolysis during the course ofMycobacterium tuberculosis infection. J. Immunol. 148 (1992) 189–196.

    Google Scholar 

  9. Murray, H. W., Scavuzzo, D. A., Kelly, C. D., Rubin, B. Y., Roberts, R. B. T4+ cell production of interferon gamma and the clinical spectrum of patients at risk for and with acquired immunodeficiency syndrome. Arch. Intern. Med. 148 (1988) 1613–1616.

    Google Scholar 

  10. Janis, E. M., Kaufmann, S. H., Schwartz, R. H., Pardoll, D. M. Activation of gamma-delta T cells in the primary immune response toMycobacterium tuberculosis. Science 244 (1989) 713–716.

    Google Scholar 

  11. Griffin, J. P., Harshan, K. V., Born, W. K., Orme, I. M. Kinetics of accumulation of gamma-delta receptor-bearing T lymphocytes in mice infected with live mycobacteria. Infect. Immun. 59 (1991) 4263–4265.

    Google Scholar 

  12. De Maria, A., Ferrazin, A., Ferrini, S., Ciccone, E., Terragna, A., Moretta, L. Selective increase of a subset of T cell receptor gamma-delta T lymphocytes in the peripheral blood of patients with human immunodeficiency virus type 1 infection. J. Infect. Dis. 165 (1992) 917–919.

    Google Scholar 

  13. Moreno, S., Baraia-Etxaburu, J., Bouza, E., Parras, F., Perez-Tascon, M., Miralles, P., Vicente, T., Alberdi, J. C., Cosin, J., Lopez-Gay, D. Risk for developing tuberculosis among anergic patients infected with HIV. Ann. Intern. Med. 119 (1993) 194–198.

    Google Scholar 

  14. Selwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, E. E., Kifin, R. S., Walker, A. T., Friedland, G. H. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N. Engl. J. Med. 320 (1989) 545–550.

    Google Scholar 

  15. Guelar, A., Gatell, J. M., Podzamczer, D., Lozano, L., Aznar, E., Miro, J. M., Mallolas, J., Zamora, L., Gonzales, J. A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS 7 (1993) 1345–1349.

    Google Scholar 

  16. Antonucci, G., Girardi, E., Raviglione, M. C., Ippolito, G., forthe Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA) Risk factors for tuberculosis in HIV-infected persons: a prospective cohort study. JAMA 274 (1995) 143–148.

    Google Scholar 

  17. Daley, C. L., Small, P. M., Schecter, G. F., Schoolnik, G. K., McAdam, R. A., Jacobs, W. R., Hopewell, P. C. An outbreak of tuberculosis with accelerated progression among persons infected with human immunodeficiency virus: an analysis using restriction-fragment-length polymorphisms. N. Engl. J. Med. 326 (1992) 231–235.

    Google Scholar 

  18. Nunn, P., Mungai, M., Nyamwaya, C., Gicheha, C., Brindle, R. J., Dunn, D. T., Githui, W., Were, J. O., McAdam, K. P. The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis. Tuber. Lung. Dis. 75 (1994) 25–32.

    Google Scholar 

  19. Small, P. M., Hopewell, P. C., Singh, S. P., Paz, A., Parsonnet, J., Ruston, D. C., Schecter, G. F., Daley, C. L., Schoolnik, G. K. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N. Engl. J. Med. 330 (1994) 1703–1709.

    Google Scholar 

  20. Alland, D., Kalkut, G. E., Moss, A. R., McAdam, R. A., Hahn, J. A., Bosworth, W., Drucker, E., Bloom, B. R. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiological methods. N. Engl. J. Med. 330 (1994) 1710–1716.

    Google Scholar 

  21. Dolin, P. J., Raviglione, M. C., Kochi, A. Global tuberculosis incidence and mortality during 1990–2000. Bull. WHO 72 (1994) 213–220.

    Google Scholar 

  22. Rieder, H. L. Opportunity for exposure and risk of infection: the fuel for the tuberculosis pandemic. Infection 23 (1995) 5–8.

    Google Scholar 

  23. Ferlinz, R., Schlegel, J. Beeinflußt AIDS die Epidemiologie der Tuberkulose? Pneumologie 49 (1995) 449–454.

    Google Scholar 

  24. Raviglione, M. C., Narain, J. P., Kochi, A. HIV-associated tuberculosis in developing countries: clinical features, diagnosis and treatment. Bull. WHO 70 (1992) 515–526.

    Google Scholar 

  25. World Health Organization The current global situation on the HIV/AIDS pandemic. Wkly. Epidemiol. Rec. 70 (1995) 353–357.

    Google Scholar 

  26. Burwen, D. R., Bloch, A. B., Griffin, L. D., Ciesielski, C. A., Stern, H. A., Onorato, I. M. National trends in the occurrence of tuberculosis and acquired immunodeficiency syndrome. Arch. Intern. Med. 155 (1995) 1281–1286.

    Google Scholar 

  27. Sudre, P., ten Dam, G., Kochi, A. Tuberculosis: a global overview of the situation today. Bull. WHO 70 (1992) 140–159.

    Google Scholar 

  28. Raviglione, M. C., Sudre, P., Rieder, H. L., Spinaci, S., Kochi, A. Secular trends of tuberculosis in Western Europe. Bull. WHO 71 (1993) 297–306.

    Google Scholar 

  29. Brodt, H. R., Staszewski, S., Enzensberger, R., Keul, H. G., Buhl, R., Hübner, K., Helm, H. E. Epidemiologie der Tuberkulose bei Patienten mit HIV-Infektion der Universitätsklinik Frankfurt. Med. Klin. 88 (1993) 279–286.

    Google Scholar 

  30. Girardi, E., Antonucci, G., Armignacco, O., Salmaso, S., Ippolito, G., andthe Italian group for the study of tuberculosis and AIDS (GISTA) Tuberculosis and AIDS: a retrospective, longitudinal, multicentre study of Italian AIDS patients. J. Infect. 28 (1994) 261–269.

    Google Scholar 

  31. Schürmann, D., Ruf, B., Mauch, H., Pohle, H. D. Tuberculosis in HIV infection: therapy and outcome. Am. Rev. Respir. Dis. 140 (Suppl. A) (1990) 267.

    Google Scholar 

  32. Bouza, E., Martin-Scapa, C., Bernaldo de Quiros, J. C. L., Martinez-Hernandez, D., Menarguez, J., Gomez-Rodrigo, J., Cosin, J., Sagues-Cifuentes, M. J High prevalence of tuberculosis in AIDS patients in Spain. Eur. J. Clin. Microbiol. Infect. Dis. 7 (1988) 785–788.

    Google Scholar 

  33. Laguna, F., Adrados, M., Diaz, F., Martinez, R., Garcia-Aguado, C., Puente, S., Gonzalez-Lahoz, J. M. AIDS and tuberculosis in Spain: a report of 140 cases. J. Infect. 23 (1991) 139–144.

    Google Scholar 

  34. Torres, R. A., Mani, S., Altholz, J., Brickner, P. W. Human immunodeficiency virus infection among homeless men in a New York City shelter. Association withMycobacterium tuberculosis infection. Arch. Intern. Med. 150 (1990) 2030–2036.

    Google Scholar 

  35. Soeiro, R., Segal-Maurer, S. Tuberculosis: nosocomial transmission and control of infection. AIDS 8 (Suppl. 1) (1994) S239-S247.

    Google Scholar 

  36. Jarvis, W. R. Nosocomial transmission of multidrug-resistantMycobacterium tuberculosis. Res. Microbiol. 144 (1993) 129–133.

    Google Scholar 

  37. Di Perri G, Cruciani, M., Danzi, M. C., Luzzati, R., De Checchi, G., Malena, M., Pizzighella, S., Mazzi, R., Solbiati, M. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet ii (1989) 1502–1504.

    Google Scholar 

  38. Perronne, C. Multiple-drug-resistant tuberculosis: current aspects in industrialized countries and future strategies. Res. Microbiol. 144 (1993) 129–133.

    Google Scholar 

  39. Chapman, S. W., Henderson, H. M. New and emerging pathogens — multiply resistantMycobacterium tuberculosis. Curr. Opin. Infect. Dis. 7 (1994) 231–237.

    Google Scholar 

  40. McGowan J. E. Nosocomial tuberculosis: new progress in control and prevention. Clin. Infect. Dis. 21 (1995) 489–505.

    Google Scholar 

  41. Graham, N. M. H., Nelson, K. E., Solomon, L., Bonds, M., Rizzo, R. T., Scavotto, J., Astemborski, J., Vlahov, D. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and seronegative intravenous drug addicts. JAMA 267 (1992) 369–373.

    Google Scholar 

  42. Markowitz, N., Hansen, N. I., Wilcosky, T. C., Hopewell, P. C., Glassroth, J., Kvale, P. A., Mangura, B. T., Osmond, D., Wallace, J. M., Rosen, M. J. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann. Intern. Med. 119 (1993) 185–193.

    Google Scholar 

  43. Jones, B. E., Young, S. M. M., Antoniskis, D., Davidson, P. T., Kramer, F., Barnes, P. F. Relationship of the manifestations of tuberculosis to CD4 counts in patients with human immunodeficiency virus infection. Am. Rev. Respir. Dis. 148 (1993) 1292–1297.

    Google Scholar 

  44. Johnson, M. P., Coberly, J. S., Clermont, H. C., Chaisson, R. E., Davis, H. L., Losikoff, P., Ruff, A. J., Boulos, R., Halsey, N. A. Tuberculin skin test reactivity among adults infected with human immunodeficiency virus. J. Infect. Dis. 166 (1992) 194–198.

    Google Scholar 

  45. Huebner, R. E., Villarino, M. E., Snider, D. E. Tuberculin skin testing and the HIV epidemic. JAMA 267 (1992) 409–410.

    Google Scholar 

  46. Moreno, S., Baraia-Etxaburu, J., Miralles, P., Berenguer, J., Cosin, J., Bernaldo de Qurios, J. C. L. Tuberculin reaction size in patients infected with HIV. AIDS 9 (1995) 1289–1290.

    Google Scholar 

  47. Centers for Disease Control and Prevention. Essential components of a tuberculosis prevention and control program; and screening for tuberculosis and tuberculosis infection in high risk populations: recommendations of the advisory council for the elimination of tuberculosis. MMWR 44 (1995) No. RR-11.

  48. Mukadi, Y., Perriens, J. H., St. Louis, M. E., Brown, C., Prignot, J., Willame, J. C., Pouthier, F., Kaboto, M., Ryder, R. W., Portaels, F. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Lancet 342 (1993) 143–146.

    Google Scholar 

  49. Nightingale, S. D., Jockusch, J. D., Haslund, R. N., Cal, S. X., Peterson, D. M., Loss, S. D. Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection. Arch. Intern. Med. 153 (1993) 1313–1318.

    Google Scholar 

  50. Schürmann, D., Bergmann, F., Jautzke, G., Fehrenbach, F. J., Mauch, H., Ruf, B. Acute and long-term efficacy of antituberculous treatment in HIV-seropositive patients with tuberculosis: a study of 36 cases. J. Infect. Dis. 26 (1993) 45–54.

    Google Scholar 

  51. Shinnik, T. M., Good, R. C. Diagnostic mycobacteriology laboratory practices. Clin. Infect. Dis. 21 (1995) 291–299.

    Google Scholar 

  52. Berenguer, J., Moreno, S., Laguna, F., Vicente, T., Adrados, M., Ortega, A., Gonzales, J., Bouza, E. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N. Engl. J. Med. 326 (1992) 668–672.

    Google Scholar 

  53. Lupatkin, H., Brau, N., Flomenberg, P., Simberkoff, M. S. Tuberculous abscesses in patients with AIDS. Clin. Infect. Dis. 14 (1992) 1040–1044.

    Google Scholar 

  54. Soriano, V., Tor, J., Gabarre, E., Muga, R. Multifocal splenic abscesses in HIV-infected drug users. AIDS 5 (1991) 901–902.

    Google Scholar 

  55. Chin, D. P., Hopewell, P. C., Yajko, D. M., Vittinghoff, E., Horsburg, C. R., Hadley, W. K., Stone, E. N., Nassos, P. S., Ostroff, S. M., Jacobson, M. A., Matkin, C. C., Reingold, A. L. Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk ofM. avium complex bacteremia in patients with human immunodeficiency virus infection. J. Infect. Dis. 169 (1994) 289–295.

    Google Scholar 

  56. Kalayjian, R. C., Toossi, Z., Tomashefski, J. F., Carey, J. T., Ross, J. A., Tomford, W., Blinkhorn, R. J. Pulmonary disease due to infection byMycobacterium avium complex in patients with AIDS. Clin. Infect. Dis. 20 (1995) 1186–1194.

    Google Scholar 

  57. Montessori, V., Phillips, P., Montaner, J., Haley, L., Craib, K., Bessuille, E., Black, W. Species distribution in human immunodeficiency virus-related mycobacterial infections: implications for selection of initial treatment. Clin. Infect. Dis. 22 (1996) 989–992.

    Google Scholar 

  58. Jones, B. E., Otaya, M., Antoniskis, D., Sian, S., Wang, F., Mercado, A., Davidson, P. T., Barnes, P. F. A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection. Am. J. Respir. Crit. Care Med. 150 (1994) 1499–1502.

    Google Scholar 

  59. Small, P. M., Schecter, G. F., Goodman, P. C., Sande, M. A., Chaisson, R. E., Hopewell, P. C. Treatment of tuberculosis in patients with advanced immunodeficiency virus infection. N. Engl. J. Med. 324 (1991) 289–294.

    Google Scholar 

  60. Soriano, E., Mallolas, J., Gatell, J. M., Latorre, X., Miro, J. M., Pecchiar, M., Mensa, J., Trilla, A., Moreno, A. Characteristics of tuberculosis in HIV-infected patients: a case-control study. AIDS 2 (1988) 429–432.

    Google Scholar 

  61. Theuer, C. P., Hopewell, P. C., Elias, D., Schecter, G. F., Rutherford, G. W., Chaisson, R. E. Human immunodeficiency virus infection in tuberculosis patients. J. Infect. Dis. 162 (1990) 8–12.

    Google Scholar 

  62. Bass, J. B., Farer, L. S., Hopewell, P. C., O'Brien, R., Jacobs, R. F., Ruben, F., Snider, D. E., Thornton, G. Treatment of tuberculosis and tuberculosis infection in adults and children. Am. J. Respir. Crit. Care Med. 149 (1994) 1359–1374.

    Google Scholar 

  63. Benson, C. A. Mycobacterium tuberculosis andMycobacterium avium complex disease in patients with HIV infection. Curr. Opin. Infect. Dis. 7 (1994) 95–107.

    Google Scholar 

  64. Cohn, D. L., Dobkin, J. F. Treatment and prevention of tuberculosis in HIV infection. AIDS 7 (1993) 195–202.

    Google Scholar 

  65. Kramer, F., Modilevsky, T., Waliany, A. R., Leedom, J. M., Barnes, P. F. Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am. J. Med. 89 (1990) 451–456.

    Google Scholar 

  66. Small, P. M., Shafer, R. W., Hopewell, P. C., Singh, S., Murphy, M. J., Desmond, E., Sierra, M. F., Schoolnik, G. K. Exogenous reinfection with multi-drug resistantMycobacterium tuberculosis in patients with advanced HIV infection. N. Engl. J. Med. 328 (1993) 1137–1144.

    Google Scholar 

  67. Centers for Disease Control Tuberculosis and human immunodeficiency virus infection: recommendations of the advisory committee for elimination of tuberculosis (ACET) MMWR 38 (1989) 236–250.

    Google Scholar 

  68. Centers for Disease Control and Prevention: Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the advisory council for the elimination of tuberculosis. MMWR 42 (1993) No. RR-7.

  69. Bloch, A. B., Cauthen, G. M., Onorato, I. M., Dansbury, K. G., Kelly, G. D., Driver, C. R., Snider, D. E. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 271 (1994) 665–671.

    Google Scholar 

  70. Borchardt, J., Kirsten, D., Jörres, R., Kroeger, C., Magnussen, H. Drug-resistant tuberculosis in Northern Germany: a retrospective hospital-based study of 1,055 patients from 1984 until 1993. Eur. Respir. J. 8 (1995) 1076–1083.

    Google Scholar 

  71. Koo, D., Royce, S., Rutherford, G. W. Drug-resistantMycobacterium tuberculosis in California, 1991–1992. West. J. Med. 163 (1995) 441–445.

    Google Scholar 

  72. Schaberg, T., Gloger, G., Reichert, B., Mauch, H., Lode, H. Drug-resistant pulmonary tuberculosis in Berlin, Germany, 1987–1993. Eur. Respir. J. 8 (1995) 278–284.

    Google Scholar 

  73. Yew, W. W., Chau, C. H. Drug-resistant tuberculosis in the 1990s. Eur. Respir. J. 8 (1995) 1184–1192.

    Google Scholar 

  74. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose 22. Informationsbericht. pmi Verlagsgruppe GmbH, Frankfurt am Main 1996.

    Google Scholar 

  75. Kochi, A., Vareldzis, B., Styblo, K. Multidrug-resistant tuberculosis and its control. Res. Microbiol. 144 (1993) 104–110.

    Google Scholar 

  76. Iseman, M. D. Treatment of multidrug-resistant tuberculosis. N. Engl. J. Med. 329 (1993) 784–791.

    Google Scholar 

  77. Park, M. M., Davis, A. L., Schluger, N. W., Cohen, H., Rom, W. N. Outcome of MDR-TB patients, 1983–1993. Prolonged survival with appropriate therapy. Am. J. Respir. Crit. Care Med. 153 (1996) 317–324.

    Google Scholar 

  78. Sumartojo, E. When tuberculosis treatment fails: a social behavioral account of patient adherence. Am. Rev. Respir. Dis. 147 (1993) 1311–1320.

    Google Scholar 

  79. Alwood, K., Keruly, J., Moore-Rice, K., Stanton, D. L., Chaulk, C. P., Chaisson, R. E. Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patients. AIDS 8 (1994) 1103–1108.

    Google Scholar 

  80. Lee, B. L., Safrin, S. Interactions and toxicities of drugs used in patients with AIDS. Clin. Infect. Dis. 14 (1992) 773–779.

    Google Scholar 

  81. Piscitelli, S. C., Flexner, C., Minor, J. R., Polis, M. A., Masur, H. Drug interactions in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 23 (1996) 685–693.

    Google Scholar 

  82. Centers for Disease Control Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin. MMWR 45 (1996) 921–925.

    Google Scholar 

  83. Mancini, P., Pasqua, F., Mazzei, L., Olliaro, P. Rifabutin treatment for tuberculosis patients with liver function abnormalities. J. Antimicrob. Chemother. 30 (1992) 242.

    Google Scholar 

  84. Schwander, S., Rüsch-Gerdes, S., Mateega, A., Lutalo, T., Tugume, S., Kityo, C., Rubaramira, R., Mugyenyi, P., Okwera, A., Mugerwa, R., Aisu, T., Moser, R., Ochen, K., M'Bonye, B., Dietrich, M. A pilot study of antituberculous combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. Tuber. Lung Dis. 74 (1993) 121–125.

    Google Scholar 

  85. Grassi, C., Peona, V. New drugs for tuberculosis. Eur. Respir. J. 8 (Suppl.) (1995) 714s-718s.

    Google Scholar 

  86. Havlir, D., Torriani, F., Dube, M. Uveitis associated with rifabutin prophylaxis againstMycobacterium avium complex infection in AIDS. N. Engl. J. Med. 329 (1993) 828–833.

    Google Scholar 

  87. Havlir, D. V., Dube, M. P., Sattler, F., Forthal, D. N., Kemper, C. A., Dunne, M. W., Parenti, D. M., Lavalle, J. P., White, A. C., Witt, M. D., Bozzette, S. A., McCutchan, J. A., forthe California collaborative treatment group Prophylaxis against disseminatedMycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. N. Engl. J. Med. 335 (1996) 392–398.

    Google Scholar 

  88. Shafran, S. D., Singer, J., Zarowny, D. P., Philipps, P., Salit, I., Walmsley, S. L., Fong, I. W., Gill, J., Rachlis, A. R., Lalonde, R. G., Fanning, M. M., Tsoukas, C. M., forthe Canadian HIV Trials Network Protocol 010 Study Group A comparison of two regimens for the treatment ofMycobacterium avium complex bacteremia in AIDS: rifabutin ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. N. Engl. J. Med. 335 (1996) 377–383.

    Google Scholar 

  89. O'Brien, R. J., Perriens, J. H. Preventive therapy for tuberculosis in HIV infection: the promise and the reality. AIDS 9 (1995) 665–673.

    Google Scholar 

  90. USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview: a summary. Ann. Intern. Med. 124 (1996) 349–368.

    Google Scholar 

  91. Selwyn, P. A., Sckell, B. M., Alcabes, P., Friedland, G. H., Klein, R. S., Schoenbaum, E. E. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA 268 (1992) 504–509.

    Google Scholar 

  92. Centers for Disease Control: National action plan to combat multidrug-resistant tuberculosis; management of persons exposed to multidrug-resistant tuberculosis. MMWR 41 (1992) No. RR-11.

  93. De Cock, K. M., Grant, A., Porter, J. D. H. Preventive therapy for tuberculosis in HIV-infected persons: international recommendations, research, and practice. Lancet 345 (1995) 833–836.

    Google Scholar 

  94. Halsey, N., Coberly, J., Atkinson, J., Boulos, R.: Twice weekly INH for TB prophylaxis. Tenth International Conference on AIDS/International Conference on STD. Yokohama, 7–12 August 1994, abstr. PBO681.

  95. Weltman, A. C., Rose, D. N. The safety of Bacille Calmette-Guérin vaccination in HIV infection and AIDS. AIDS 7 (1993) 149–157.

    Google Scholar 

  96. Centers for Disease Control and Prevention: Guidelines for preventing the transmission ofMycobacterium tuberculosis in health-care facilities. MMWR 43 (1994) No. RR-13.

Download references

Author information

Authors and Affiliations

  1. II. Medizinische Klinik (Infektiologie), Virchow-Klinikum, Humboldt-Universität zu Berlin, Berlin, Germany

    D. Schürmann M. D. & F. Bergmann M. D.

  2. Food and Drug Administration, Rockville, MD, USA

    S. D. Nightingale M. D.

  3. 2. Klinik für Innere Medizin (Infektions- und Tropenmedizin), Städtisches Klinikum St. Georg, Delitzscher Str. 141, D-04129, Leipzig, Germany

    B. Ruf M. D.

Authors
  1. D. Schürmann M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. D. Nightingale M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Bergmann M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Ruf M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Dedicated to ProfessorHans D. Pohle on the occasion of his 65th birthday.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schürmann, D., Nightingale, S.D., Bergmann, F. et al. Tuberculosis and HIV infection: A review. Infection 25, 274–280 (1997). https://doi.org/10.1007/BF01720396

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01720396

Keywords

Search

Navigation